08 Feb 2025
M-TEER for secondary mitral regurgitation
Anchorperson:
M. Amaki
Summary
Managing secondary mitral regurgitation with M-TEER requires a tailored approach. This PCR Tokyo Valves 2025 session explores key considerations for atrial functional MR and VFMR beyond COAPT criteria, helping you refine patient selection, procedural strategies, and post-treatment management through expert insights and real-world cases.
Learning Objectives
- To better understand the therapeutic tips for the atrial functional mitral regurgitation with extremely flat valve
- To identify the best candidate for surgery in atrial functional mitral regurgitation
- To decide whether you should undergo M-TEER for VFMR patients with non-COAPT patient with large left ventricle, pulmonary hypertension, etc.
- To understand what is the best pre-to-post treatment strategy for M-TEER with non-COAPT patient with large gap
